Other public direct selling companies have been attacked by this individual and his network of associates using the same blueprint of allegations before retracting or disavowing their unsubstantiated allegations as part of an announced settlement. Medifast believes that any investigation, regulatory or otherwise, should be focused on the false allegations and stock dealings of Mr. Minkow, Mr. Fitzgerald and their co-conspirators to harm Medifast, Inc., our over 360 Maryland-based employees, 122 Medifast clinic associates, our 5,800 dedicated nationwide health coaches and our loyal shareholders.
Medifast respectfully suggests its team members and shareholders keep in mind that the widespread acceptance of the Medifast products by our customers who want to improve their health through a proven, clinically tested, weight loss program is the important focus of the Medifast core mission. The periodic audited Medifast financial reports reflect in large measure the success its growing customer base has seen in achieving their weight loss goals and enjoying a healthier lifestyle as they take shape for life.
Michael S. McDevitt, chief executive officer of Medifast, Inc., said, "Our diversified product distribution model continues to operate very efficiently and we believe that will continue to be the case for the foreseeable future. We will be reporting year-end financial results in early to '/>"/>
|SOURCE Medifast, Inc.|
Copyright©2010 PR Newswire.
All rights reserved